Navigation Links
Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)
Date:9/23/2014

DUBLIN, Sept. 23, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies)" report to their offering.

This report defines markets and identifies trends for proteomics applications, both in their research use and in IVD.  Proteomics is the study of proteins, including the study of the structure and function of proteins. This includes the study of which proteins are expressed, when and where they are expressed, structure of proteins, roles of proteins, and interactions of proteins. Proteomics is a large field that has focused on research markets but has applications in therapeutics and diagnostics.   

Understanding the human proteome is a much larger and more challenging task than the Human Genome Project was. The proteome is much more complex as it can change based on factors that affect which genes are expressed. Also, after proteins are expressed, proteins may be modified. Proteomics will remain a very active area of research for several years, and the knowledge derived from this research is expected to produce advances in the diagnosis and treatment of diseases.r decades, many advances are being made in this field. Other major technology segments include chromatography, electrophoresis, microarrays, and other technologies. 

Companies discussed in this report include those who with proteomics platforms and related products, commercializing technologies such as mass spectrometry or other proteomics technologies. In addition, this report discusses the proteomics research, services, and products developed and marketed by companies using these proteomics technologies and platforms. Many of the companies in this second group have developed their own proprietary proteomic technologies that utilize technologies such as mass spectrometry or other proteomic technologies.

Key Topics Covered:

CHAPTER ONE: EXECUTIVE SUMMARY

CHAPTER TWO: INTRODUCTION

CHAPTER THREE: TECHNOLOGIES

CHAPTER FOUR: PROTEOMICS APPLICATIONS

CHAPTER FIVE: INVESTMENTS AND FINANCING AGREEMENTS FOR PROTEOMICS COMPANIES

CHAPTER SIX: CONSORTIA

CHAPTER SEVEN: ISSUES AND TRENDS

CHAPTER EIGHT: MARKET ANALYSIS

CHAPTER NINE: COMPANIES MARKETING OR DEVELOPING PROTEOMICS TOOLS AND PLATFORMS

  • Abbott Laboratories
  • AB SCIEX (A Danaher Corporation Company)
  • ActivX Biosciences, Inc. (Owned by Kyorin Pharmaceuticals)
  • Advion, Inc.
  • Affymetrix, Inc.
  • Arbor Vita Corporation
  • ArcDia International Oy Ltd
  • Arrayit Corporation
  • Atonomics A/S
  • Avant Diagnostics, Inc.
  • Axela, Inc.
  • AXO Science
  • AYOXXA Biosystems GmbH
  • Banyan Biomarkers
  • Beckman Coulter, Inc.
  • (Subsidiary of Danaher Corporation)
  • Becton, Dickinson and Company (BD)
  • BG Medicine, Inc.
  • BioAnalyte Inc.
  • Biocartis SA
  • Biodesix, Inc.
  • Biognosys AG
  • bioMérieux SA
  • BioMosaics Inc.
  • Bioproximity, LLC
  • Bio-Rad Laboratories, Inc.
  • Biosensia Ltd.
  • BioSystems International
  • Bruker Corporation
  • Cambridge Protein Arrays Ltd.
  • Caprion, Inc.
  • caprotec bioanalytics GmbH
  • CardioGenics Holdings, Inc.
  • CD Diagnostics, Inc.
  • CDI Laboratories
  • Chromsystems Instruments & Chemicals GmbH
  • Clearbridge BioLoc Pte Ltd.
  • Courtagen Life Sciences, Inc.
  • CovalX AG
  • CRELUX GmbH
  • Crescendo Bioscience (Subsidiary of Myriad Genetics)
  • CyVek Inc.
  • Danaher Corporation
  • Dasit Group - Focusing on
  • DECODON GmbH
  • DiAssess Inc.
  • Digilab, Inc.
  • Dualsystems Biotech AG
  • EMD
  • Euroimmun AG
  • Evotec AG
  • Expedeon, Inc.
  • Fluidigm
  • Fujirebio Inc.
  • GE Healthcare Life Sciences
  • Genalyte, Inc.
  • GeneFluidics, Inc.
  • Geneva Bioinformatics (GeneBio) SA
  • GWC Technologies
  • Helena Laboratories
  • Hoefer, Inc. (Subsidiary of Harvard Bioscience, Inc.)
  • Hybrigenics SA
  • ImaBiotech SAS
  • Immunexpress Group
  • Immunovia AB
  • InDevR, Inc.
  • Insilicos LLC
  • Integrated Diagnostics, Inc.
  • Integromics S.L.
  • Intuitive Biosciences, Inc.
  • JOEL Ltd.
  • KineMed, Inc.
  • Kinexus
  • LEAP Technologies, Inc.
  • Life Technologies Corporation
  • LSI Medience Corporation
  • Luminex Corporation
  • MagArray Inc.
  • Matrix Science Limited
  • MBio Diagnostics, Inc.
  • Microlytic ApS
  • QuantiScientifics, LLC
  • Quidel Corporation
  • Rigaku Reagents, Inc.
  • Roche Diagnostics
  • Sebia, Inc.
  • Sera Prognostics, Inc.
  • Shimadzu Corporation
  • Siemens Healthcare Diagnostics
  • Sigma-Aldrich Corporation
  • Singulex, Inc.
  • SISCAPA Assay Technologies, Inc.
  • SomaLogic, Inc.
  • SpOtOn Clinical Diagnostics Limited
  • SQI Diagnostics Inc.
  • STAT-Diagnostica
  • Syngene (Division of Synoptics Ltd)
  • T2 Biosystems, Inc.
  • Tecan Group AG
  • The Binding Site Group Ltd.
  • Theranostics Health Inc.
  • Thermo Fisher Scientific, Inc.
  • Tosoh Corporation
  • Venaxis, Inc. (Formerly Aspen BioPharma, Inc.)
  • Wako Diagnostics
  • Waters Corporation

For more information visit http://www.researchandmarkets.com/research/sccg6n/proteomics

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


'/>"/>
SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific
2. Global Genomics and Proteomics Analytical Instruments Market 2014-2018
3. Waters Teams With Biochemical Society on Proteomics Training Day and Symposium
4. Elsevier Launches New Open Access Journal: Translational Proteomics
5. Director of Proteomics at the Broad Institute of MIT and Harvard, Steven Carr, to Deliver Pittcon 2014 Wallace H. Coulter Plenary Lecture
6. Research and Markets: Proteomics - Technologies, Markets and Companies - 2013 Report
7. Invisible Sentinel's Test for Wine-Spoilage Microbe to be Distributed by Enartis in Multiple Markets Globally
8. Human Reproductive Technologies: Products and Global Markets
9. OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing
10. Molecular Diagnostics Markets
11. Microarray Markets - 2013 Report Examines Companies that are Actively Developing and Marketing Microarray Instrumentation or Microarray Biochips
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/8/2019)... (PRWEB) , ... April 08, 2019 , ... US ... investors a $15 million preferred equity investment in the privately held pharmaceutical company, S1 ... leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready ...
(Date:4/4/2019)... ... April 02, 2019 , ... Biomeme, Inc. , ... it’s latest field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called ... to Rosland Franklin, an English chemist and X-ray crystallographer who made significant contributions ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced ... proceeded with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility ... top of the $1.7 million already awarded by CARB-X. The additional $1.7M will ...
(Date:3/27/2019)... ... March 27, 2019 , ... In honor of National Nutrition Month, Lajollacooks4u has ... healthy meals and good nutrition. This month, Chef Jodi Abel appeared on two ... , The first segment addressed the nutritional value of USDA’s MyPlate, a nutrition ...
Breaking Biology Technology:
(Date:4/4/2019)... ALISO VIEJO, Calif. (PRWEB) , ... April 02, ... ... a leading clinical genetics testing company, will present results demonstrating that RNA genetic ... hereditary cancer genetic testing. This study, awarded as a Top Rated poster, is ...
(Date:4/1/2019)... ... April 01, 2019 , ... uBiome announces ... Related Conditions” by the US Patent and Trademark Office on January 1, 2019 ... by uBiome collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. Jessica Richman, ...
(Date:3/29/2019)... ... March 28, 2019 , ... In the development of biosimilars, the broad definition ... this task. Despite this uncertainty, several manufacturers have been successful and numerous follow-on biologics ... of this webinar, learn how analytical similarity is achieved in biosimilars based on recently ...
Breaking Biology News(10 mins):